NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

Tapentadol的全球市場:各應用領域(咳嗽治療,疼痛管理),各終端用戶(診療所,醫院,藥局)的市場調查,預測(∼2025年),COVID-19的累積性的影響

Tapentadol Market Research Report by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1005093
出版日期 內容資訊 英文 198 Pages
商品交期: 最快1-2個工作天內
價格
Tapentadol的全球市場:各應用領域(咳嗽治療,疼痛管理),各終端用戶(診療所,醫院,藥局)的市場調查,預測(∼2025年),COVID-19的累積性的影響 Tapentadol Market Research Report by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 198 Pages
簡介

全球Tapentadol的市場規模預測將從2020年的32億3,877萬美元,擴大到2025年末的42億339萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察,分析,與預測。

 

這份報告提供Tapentadol的世界市場調查,提供市場概要,市場成長要素及阻礙因素分析,市場機會,COVID-19的影響,應用·終端用戶·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查涵蓋年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃的作成
    • 實行:調查的實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 應用預測
  • 終端用戶預測
  • 地區預測
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 各應用領域

  • 咳嗽治療
  • 疼痛管理
    • 癌症性疼痛
    • 神經性疼痛

第7章 各終端用戶

  • 診療所
  • 醫院
  • 藥局

第8章 南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東·非洲

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • Allergan, Plc
  • Aristo Pharmaceuticals Pvt. Ltd.
  • Cadila Pharmaceuticals Ltd.
  • Depomed, Inc.
  • Grunenthal
  • IPCA Laboratories Ltd.
  • Janssen Pharmaceutical, Inc.
  • Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
  • Lupin Laboratories Ltd.
  • Manus Aktteva Biopharma LLP.
  • NIKSAN PHARMA CHEM
  • Ranbaxy Laboratories Ltd.
  • Sun Pharmaceutical Industries Limited
  • Taj Pharma (India) Ltd.
  • Tirupati Medicare Ltd
  • Treatwell Biotech

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-43676CF42C35

The Global Tapentadol Market size was estimated at USD 3,238.77 Million in 2020 and expected to reach USD 3,428.31 Million in 2021, at a Compound Annual Growth Rate (CAGR) 6.19% to reach USD 4,644.07 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Tapentadol to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Application, the Tapentadol Market was studied across Cough Treatment and Pain Management. The Pain Management is further studied across Cancer Pain and Neuropathic Pain.

Based on End User, the Tapentadol Market was studied across Clinic, Hospital, and Pharmacy.

Based on Geography, the Tapentadol Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Tapentadol Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Tapentadol Market, including Allergan, Plc, Aristo Pharmaceuticals Pvt. Ltd., Cadila Pharmaceuticals Ltd., Depomed, Inc., Grunenthal, IPCA Laboratories Ltd., Janssen Pharmaceutical, Inc., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Lupin Laboratories Ltd., Manus Aktteva Biopharma LLP., NIKSAN PHARMA CHEM, Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Limited, Taj Pharma (India) Ltd., Tirupati Medicare Ltd, and Treatwell Biotech.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Tapentadol Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tapentadol Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tapentadol Market?
  • 4. What is the competitive strategic window for opportunities in the Global Tapentadol Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Tapentadol Market?
  • 6. What is the market share of the leading vendors in the Global Tapentadol Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Tapentadol Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Application Outlook
  • 3.4. End User Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High occurrence of chronic musculoskeletal pain
      • 5.1.1.2. Rising demand for over-the-counter painkillers
      • 5.1.1.3. Growing requirement for packaging materials
      • 5.1.1.4. Escalating prevalence of diabetes and increasing need for analgesics
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with tapentadol
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in treatment and surging consumer awareness
      • 5.1.3.2. Investments in R&D to develop advanced grades of tapentadol
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government regulations and availability of substitute
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Tapentadol Market, by Application

  • 6.1. Introduction
  • 6.2. Cough Treatment
  • 6.3. Pain Management
    • 6.3.1. Cancer Pain
    • 6.3.2. Neuropathic Pain

7. Tapentadol Market, by End User

  • 7.1. Introduction
  • 7.2. Clinic
  • 7.3. Hospital
  • 7.4. Pharmacy

8. Americas Tapentadol Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Tapentadol Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Tapentadol Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Allergan, Plc
  • 12.2. Aristo Pharmaceuticals Pvt. Ltd.
  • 12.3. Cadila Pharmaceuticals Ltd.
  • 12.4. Depomed, Inc.
  • 12.5. Grunenthal
  • 12.6. IPCA Laboratories Ltd.
  • 12.7. Janssen Pharmaceutical, Inc.
  • 12.8. Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
  • 12.9. Lupin Laboratories Ltd.
  • 12.10. Manus Aktteva Biopharma LLP.
  • 12.11. NIKSAN PHARMA CHEM
  • 12.12. Ranbaxy Laboratories Ltd.
  • 12.13. Sun Pharmaceutical Industries Limited
  • 12.14. Taj Pharma (India) Ltd.
  • 12.15. Tirupati Medicare Ltd
  • 12.16. Treatwell Biotech

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL TAPENTADOL MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL TAPENTADOL MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL TAPENTADOL MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL TAPENTADOL MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL TAPENTADOL MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL TAPENTADOL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL TAPENTADOL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TAPENTADOL MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 10. GLOBAL TAPENTADOL MARKET SIZE, BY COUGH TREATMENT, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL TAPENTADOL MARKET SIZE, BY COUGH TREATMENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL TAPENTADOL MARKET SIZE, BY CANCER PAIN, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL TAPENTADOL MARKET SIZE, BY CANCER PAIN, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL TAPENTADOL MARKET SIZE, BY NEUROPATHIC PAIN, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL TAPENTADOL MARKET SIZE, BY NEUROPATHIC PAIN, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL TAPENTADOL MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 19. GLOBAL TAPENTADOL MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TAPENTADOL MARKET SIZE, BY END USER, 2026
  • FIGURE 21. GLOBAL TAPENTADOL MARKET SIZE, BY CLINIC, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL TAPENTADOL MARKET SIZE, BY CLINIC, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL TAPENTADOL MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL TAPENTADOL MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL TAPENTADOL MARKET SIZE, BY PHARMACY, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL TAPENTADOL MARKET SIZE, BY PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. AMERICAS TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 28. AMERICAS TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 30. ARGENTINA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 31. BRAZIL TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. CANADA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. MEXICO TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. UNITED STATES TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. CALIFORNIA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. FLORIDA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. ILLINOIS TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. NEW YORK TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. OHIO TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. PENNSYLVANIA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. TEXAS TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 43. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 45. CHINA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. INDIA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. INDONESIA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. JAPAN TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. MALAYSIA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. PHILIPPINES TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. SOUTH KOREA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. THAILAND TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 54. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 56. FRANCE TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. GERMANY TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. ITALY TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. NETHERLANDS TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. QATAR TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. RUSSIA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. SPAIN TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. GLOBAL TAPENTADOL MARKET: FPNV POSITIONING MATRIX
  • FIGURE 68. GLOBAL TAPENTADOL MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 69. GLOBAL TAPENTADOL MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TAPENTADOL MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL TAPENTADOL MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL TAPENTADOL MARKET SIZE, BY COUGH TREATMENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL TAPENTADOL MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL TAPENTADOL MARKET SIZE, BY CANCER PAIN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL TAPENTADOL MARKET SIZE, BY NEUROPATHIC PAIN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL TAPENTADOL MARKET SIZE, BY CLINIC, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL TAPENTADOL MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL TAPENTADOL MARKET SIZE, BY PHARMACY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. ARGENTINA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. ARGENTINA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. BRAZIL TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. BRAZIL TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. CANADA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. CANADA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. MEXICO TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. MEXICO TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. UNITED STATES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. UNITED STATES TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CALIFORNIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CALIFORNIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. FLORIDA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. FLORIDA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. ILLINOIS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ILLINOIS TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. NEW YORK TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. NEW YORK TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. OHIO TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. OHIO TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. PENNSYLVANIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. PENNSYLVANIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. TEXAS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. TEXAS TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ASIA-PACIFIC TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. CHINA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. CHINA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. INDIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. INDONESIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. INDONESIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. JAPAN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. JAPAN TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. MALAYSIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. MALAYSIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. PHILIPPINES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PHILIPPINES TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. SOUTH KOREA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. SOUTH KOREA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. THAILAND TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. THAILAND TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. FRANCE TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. FRANCE TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. GERMANY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. GERMANY TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. ITALY TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. ITALY TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. NETHERLANDS TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. NETHERLANDS TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. QATAR TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. QATAR TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. RUSSIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. RUSSIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SAUDI ARABIA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SOUTH AFRICA TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SPAIN TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SPAIN TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. UNITED ARAB EMIRATES TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. UNITED KINGDOM TAPENTADOL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. GLOBAL TAPENTADOL MARKET: SCORES
  • TABLE 85. GLOBAL TAPENTADOL MARKET: BUSINESS STRATEGY
  • TABLE 86. GLOBAL TAPENTADOL MARKET: PRODUCT SATISFACTION
  • TABLE 87. GLOBAL TAPENTADOL MARKET: RANKING
  • TABLE 88. GLOBAL TAPENTADOL MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 89. GLOBAL TAPENTADOL MARKET: SHARE, BY COMPANY, 2020
  • TABLE 90. GLOBAL TAPENTADOL MARKET: MERGER & ACQUISITION
  • TABLE 91. GLOBAL TAPENTADOL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 92. GLOBAL TAPENTADOL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 93. GLOBAL TAPENTADOL MARKET: INVESTMENT & FUNDING
  • TABLE 94. GLOBAL TAPENTADOL MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 95. GLOBAL TAPENTADOL MARKET: LICENSE & PRICING
  • TABLE 96. GLOBAL TAPENTADOL MARKET: CONTACT DETAILS